Cerebras shares jump 15.88% as hedge funds pile in
Cerebras Systems Inc. (NASDAQ: CBRS) shares jumped 15.88% to $253.76 on Monday, recovering from post-earnings lows as major institutions including Tiger Global and Citadel disclosed new stakes. Wedbush raised its price target to $290, citing the company's expanded OpenAI partnership and rising demand from neo-cloud providers diversifying away from NVIDIA. Management raised full-year 2026 core revenue guidance to $880-$890 million.
*this image is generated using AI for illustrative purposes only.
Cerebras Systems Inc. (NASDAQ: CBRS) shares surged 15.88% to $253.76 in Monday morning trading, marking a sharp recovery from the 18.63% decline seen in premarket trading following its second-quarter 2026 earnings report. The rally was driven by a wave of institutional position disclosures filed after Friday’s close, alongside renewed investor confidence in management’s upbeat 2027 demand commentary and raised fiscal 2026 outlook.
Institutional Accumulation
The price action reflects significant interest from prominent hedge funds building sizable stakes during the second quarter. Chase Coleman’s Tiger Global Management disclosed a massive new position of nearly 3.0 million shares valued at $663 million, marking one of the firm’s largest new technology bets. Ken Griffin’s Citadel Advisors revealed a 1.25 million-share stake accompanied by extensive call option holdings. Altimeter Capital and Atreides Management also reported significant equity positions.
Additionally, Cathie Wood’s ARK Invest bought 106,941 shares (valued at roughly $28 million) across its ARKK and ARKW ETFs on August 13, stepping in to purchase the post-earnings selloff directly. Even with Monday’s bounce, the stock is navigating key technical levels, trading above its 20-day moving average of $224.50 while attempting to reclaim previous ranges. Shares have gained nearly 50% over the trailing month.
Analyst Upgrades and OpenAI Partnership
Wedbush analyst Matt Bryson raised his price target on Cerebras from $280 to $290, maintaining an Outperform rating. Bryson highlighted the launch of “Ultrafast,” a new API service tier for OpenAI’s GPT-5.6 Sol model, which runs at up to 750 output tokens per second—speeds up to 14 times faster than standard processing. He noted that OpenAI remains committed to taking 750 MW of Cerebras capacity by 2028, with contract options allowing for additional capacity through 2030.
Neo-Cloud Diversification and Guidance
The rally serves as a sentiment reset after the stock fell last week despite posting record core revenue of $209.9 million, up 103% year-over-year. The initial pressure stemmed from GAAP revenue of $180.11 million missing the Street estimate of $194.2 million by 7.26%. CEO Andrew Feldman framed this as a temporary swing rather than a structural bottleneck, emphasizing that emerging neo-cloud providers are diversifying away from single-vendor GPU dependence on NVIDIA Corporation (NASDAQ: NVDA).
Management raised its full-year 2026 core revenue guidance to $880 million to $890 million, with gross margins expected between 41% and 43%. Feldman described the shift toward multi-vendor stacks or Advanced Micro Devices, Inc. (NASDAQ: AMD) hardware as creating “large” opportunities for Cerebras in 2027. The company’s remaining performance obligations stand at $25.4 billion, providing substantial revenue visibility as capacity expands.
What the Numbers Show
The divergence between the initial sell-off and the subsequent institutional buying underscores a market reassessment of Cerebras’ growth trajectory. While GAAP metrics missed due to non-cash adjustments (including $44.3 million in amortization of customer warrant assets), core fundamentals strengthened significantly. Core gross margin expanded to 40.6%, an improvement of approximately 940 basis points year-over-year. The combination of a robust balance sheet—featuring $8.6 billion in cash and equivalents—and a $25.4 billion backlog suggests that the recent volatility was driven by short-term accounting nuances rather than underlying business health.
| Metric | Reported | Estimate | Variance |
|---|---|---|---|
| GAAP Revenue: | $180.110 million | $194.202 million | -7.26% |
| Core Revenue: | $210 million | N/A | >100% YoY |
| GAAP EPS Loss: | $(2.98) | $(1.41) | +111.35% |
| Adj EPS Loss: | $(0.04) | $(0.17) | +76.47% |
| Stock Price Change (Mon): | +15.88% | N/A | $253.76 |
How might the diversification of neo-cloud providers away from NVIDIA's GPU monopoly impact Cerebras' market share and competitive positioning in 2027?
What are the potential risks associated with Cerebras' heavy reliance on the $25.4 billion backlog, particularly if macroeconomic conditions slow AI infrastructure spending?
Could the significant institutional accumulation by firms like Tiger Global and Citadel signal a broader shift in investor sentiment toward alternative AI chip manufacturers?
16
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
